Hyperbaric oxygen (HBO) has been used for treatment of conditions involving oxygenation accidents as seen in scuba diving and high altitude sports activities like mountain climbing. We demonstrate in the present study that HBO is potentially therapeutic for ameliorating post-ischemic stroke symptoms. Adult Sprague-Dawley rats received middle cerebral artery occlusion (MCAo) for 1 hour, and thereafter animals were introduced to: a) immediate 1 hour HBO (3 atm) or 1 hour hyperbaric pressure (HBP, 3 atm); b) 1 hour delay, which corresponded to 1 hour reperfusion, prior to 1 hour HBO or HBP treatment; or c) no treatment at all. Behavioral examination using the elevated body swing test at 24 and 48 hours after reperfusion revealed that almost all animals exposed to immediate HBO did not display biased swing activity, a few animals in the 1 hour delay HBO and immediate HBP treatment groups also exhibited near symmetrical swing activity, whereas all the animals in the delayed HBP treatment and in the no treatment groups showed asymmetrical response. At 48 hours after reperfusion, triphenyltetrazolium chloride staining revealed that animals exposed to immediate HBO treatment showed no detectable brain infarction: a few animals in the delayed HBO and immediate HBP treatment groups also exhibited absence of brain infarction, but the rest of the animals displayed the characteristic brain infarction produced by MCAo. The present results indicate the efficacy of HBO and, to some extent, by early HBP in ameliorating ischemia-induced brain damage and behavioral dysfunctions, which are not fully addressed by current therapeutic strategies for stroke. (Supported by National Defense Medical Center, Taiwan). - Stroke

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000429-01
Application #
6227909
Study Section
Special Emphasis Panel (CNRL)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Chou, J; Luo, Y; Kuo, C-C et al. (2008) Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neuroscience 151:92-103
Chen, Yuan-Hao; Harvey, Brandon K; Hoffman, Alexander F et al. (2008) MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector. FASEB J 22:261-75
Harvey, B K; Chen, G J; Schoen, C J et al. (2007) An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of stroke. Cell Transplant 16:483-91
Chen, Guann-Juh; Harvey, Brandon K; Shen, Hui et al. (2006) Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. J Neurosci Res 84:1848-55
Woods, Amina S; Kaminski, Rafal; Oz, Murat et al. (2006) Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity. J Proteome Res 5:1017-23
Harvey, Brandon K; Hoffer, Barry J; Wang, Yun (2005) Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Pharmacol Ther 105:113-25
Harvey, B K; Mark, A; Chou, J et al. (2004) Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Brain Res 1022:88-95
Cox, Suyu; Harvey, Brandon K; Sanchez, Joseph F et al. (2004) Mediation of BMP7 neuroprotection by MAPK and PKC IN rat primary cortical cultures. Brain Res 1010:55-61
Harvey, B K; Chang, C F; Chiang, Y H et al. (2003) HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp Neurol 183:47-55
Chang, Chen-Fu; Lin, Shinn-Zong; Chiang, Yung-Hsiao et al. (2003) Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34:558-64

Showing the most recent 10 out of 11 publications